Write in a clean editor, then format for The Journal of Medicine Access in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
The Journal of Medicine Access is a peer-reviewed journal published by SAGE, covering Pharmaceutical Economics and Policy, Pharmaceutical Quality and Counterfeiting, Pharmaceutical Practices and Patient Outcomes.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', The Journal of Medicine Access, 12(3), pp. 45–58.
Formats any DOI in The Journal of Medicine Access style. No sign-up. |
| Publishes research in | Pharmaceutical Economics and Policy Pharmaceutical Quality and Counterfeiting Pharmaceutical Practices and Patient Outcomes Telemedicine and Telehealth Implementation Medication Adherence and Compliance |
| ISSN | 2755-0834 |
| Citation impact (2-yr) | 2.16 |
| h-index | 11 |
| i10-index | 15 |
| Total citations | 399 |
| Top institutions publishing here | Jimma University |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Simultaneous expansion of the Internet and increased globalisation of the pharmaceutical industry have meant medication can be accessed transnationally from both legal and illicit sources. This has coincided with the rise of substandard and falsified medicines (SFMs) online. These products fail to meet regulatory or quality standards and/or are constituted with substandard ingredients, causing undesired…
Background: Substandard and falsified (SF) medical products are removed from circulation through a process called 'product recall' by medicines regulatory agencies. In Zambia, the Zambia Medicines Regulatory Authority (ZAMRA) is responsible for recalling SF medical products from the Zambian market through passive and active surveillance methods. This study aimed to describe the prevalence of recalls…
Background: Many governments encouraged generic use to enhance health equality and minimise health expenditure. The lack of knowledge and acceptance of generic medicines are the main barriers to their use. Objectives: This study aimed to assess population knowledge and perception towards generic drugs, identify their primary sources of information and examine which variables are independently…
Background: Community pharmacists played an essential role in the control and management of the COVID-19 pandemic; both pharmaceutical care and community pharmacists were affected, given that, patients' needs and demands increased due to the fear of lockdowns and shortage of medication throughout the pandemic. Objectives: This study was based in Lebanon and aimed to assess…
Substandard and falsified (SF) medicines are a global health challenge with the World Health Organization (WHO) estimating that 1 in 10 of medicines in low- and middle-income countries (LMICs) are SF. Antimicrobials (i.e. antimalarials, antibiotics) are the most commonly reported SF medicines. SF medicines contribute significantly to the global burden of infectious diseases and antimicrobial…
